Detalles de la búsqueda
1.
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.
J Infect Dis
; 202(5): 705-16, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20662716
2.
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Clin Infect Dis
; 40(6): 853-8, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15736019
3.
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
AIDS
; 16(8): 1147-54, 2002 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-12004273
4.
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
Clin Infect Dis
; 37(4): 551-8, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12905140
5.
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.
Vaccine
; 27(43): 6088-94, 2009 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19450647
6.
A reporting tool for real-time assessment of study data availability.
Clin Trials
; 1(3): 339-40, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-16279259
7.
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.
J Infect Dis
; 188(10): 1444-54, 2003 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14624369
8.
Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation.
J Acquir Immune Defic Syndr
; 29(4): 356-62, 2002 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11917239
9.
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
J Acquir Immune Defic Syndr
; 36(1): 576-87, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15097300
10.
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3).
J Acquir Immune Defic Syndr
; 32(3): 281-6, 2003 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12626887
Resultados
1 -
10
de 10
1
Próxima >
>>